PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 9 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Mechanism of action
Clinical evidence
A polyherbal formulation containing Mandukaparni (Medha Plus) ameliorated cognitive deficits and associated pathological hallmarks [PMID:35617801]
An organic extract containing Mandukaparni, among other ingredients, contributed to the correction of lipid profiles, blood pressure, and psychological factors such as anxiety and depression over 6 months [PMID:22556998]
Evidence summary
PubMed sources
- 1.PMID: 41164654 (2025) — A Comprehensive Literature Review On Kushmanda (Benincasa Hispida Thunip) As Medhya (IQ Booster). · Journal of pharmacy & bioallied sciences
- 2.PMID: 18931935 (2008) — Neuronutrient impact of Ayurvedic Rasayana therapy in brain aging. · Biogerontology
- 3.PMID: 35617801 (2022) — Medha Plus - A novel polyherbal formulation ameliorates cognitive behaviors and disease pathology in models of Alzheimer's disease. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
- 4.PMID: 22556998 (2000) — Individuals at Risk of Coronary Heart Disease (CHD), its Prevention and Management by an Indigenous Compound. · Ancient science of life